Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aquamin for Halitosis
NCT05058638Phase 2Recruiting
- Sponsor
- University of Michigan
- Start
- Aug 2022
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in halitosis, sponsored by University of Michigan. Primary endpoint: Halitosis Associated Life-quality Test at 90 days. Started Aug 2022; status: recruiting.
02
Conditions
halitosis
Beyond the preview
Go deeper on NCT05058638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05058638.